Mark Rabbat, MD, discusses the Society of Cardiovascular Computed Tomography's efforts to make an impact by lobbying in Washington. 

The advanced AI model, developed by Anumana with help from Mayo Clinic, could provide value as a screening tool for heart failure.

Carlyle Group, one of the world’s largest private equity firms, is reportedly working to buy the two business units and turn them into a brand new company. 

The total value of the acquisition, first announced in 2022, is dependent on various regulatory and commercial milestones.

Researchers examined data from nearly 60,000 adults, focusing on individuals who have been diagnosed with Cannabis Use Disorder. 

A majority of patient deaths within two years of TAVR can be linked to cardiovascular complications, according to new research published in JACC: Cardiovascular Interventions. Can follow-up care be improved to combat this trend? 

The FDA is expected to base its decision in part on the STELLAR clinical trial, which included 163 adult patients treated with subcutaneous sotatercept and 160 patients treated with a placebo.

How common is it for patients to present with overlapping cardiac, renal and metabolic issues? A new analysis in JAMA Cardiology explored that very question.

The free webinar, scheduled for Sept. 29, will examine the benefits of using CCTA and FFR-CT to manage chest pain patients.